ChartRow logo
ChartRow
Investing Charts
Sign in
TECH
Bio-TechneStock · HealthcareS&P 500 0.0%
$71.60−$0.17 (-0.24%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

How Bio-Techne makes money

Period

How does Bio-Techne make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Bio-Techne · FY2025 · year ended 2025-06-30
Revenue$1.2BGross profit$790M · 65%Cost of revenue$429M · 35%Operating income$102M · 8%Operating expenses$688M · 56%R&D$99M · 8%SG&A$589M · 48%Net income$73M · 6%Income tax$25M · 2%Consumables$972M · 80%Instruments$112M · 9%Service$112M · 9%Royalty$24M · 2%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.